Alector to Host Mid-Year Earnings Conference Call
PremiumPress ReleasesAlector to Host Mid-Year Earnings Conference Call
2M ago
Alector participates in a conference call with Cantor Fitzgerald
Premium
The Fly
Alector participates in a conference call with Cantor Fitzgerald
2M ago
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer’s Association International Conference® 2024 (AAIC®)
Premium
Press Releases
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer’s Association International Conference® 2024 (AAIC®)
2M ago
Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
PremiumPress ReleasesAlector to Host Fourth Quarter and Full-Year 2023 Earnings Call
7M ago
Alector announces first patient dosed in PROGRESS-AD Phase 2 trial
Premium
The Fly
Alector announces first patient dosed in PROGRESS-AD Phase 2 trial
8M ago
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
Premium
Press Releases
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100